Charles Rowland Jr - Director, Viking Therapeutics, Inc

As of January 6, 2021


Charles Rowland Jr Net Worth

  • Net worth is estimated to be at least $5.82M
  • Owns at least 30,000 units of Viking Therapeutics, Inc stock

Charles Rowland Jr Trading

  • Largest purchase of shares was 30,000 units , worth over $154.8K on May 31, 2018
  • In total has made about 6 transactions over 4 years
  • Usually trades in January, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Charles Rowland Jr Mailing Address

  • Mailing address is 3338 Lancashire Rd Furlong PA 18925 PA

Viking Therapeutics, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Brian Lian, Ph.D. 2020 $577,000 $301,000 $2,485,102 $1,824,346 - $5,187,448
Brian Lian, Ph.D. 2019 $525,000 $210,000 $1,530,379 $1,246,740 - $3,512,119
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1607678/000156459021018175/vktx-def14a_20210520.htm

Viking Therapeutics, Inc Insider Trading

  • The most recent transaction was 20,000 units bought on June 10, 2021 by Matthew Foehr worth over $113.8K
  • In the last 6 years, insiders at Viking Therapeutics, Inc sold an estimated value of $7.64M and bought an estimated value of $2.38M
  • The most active traders are Michael Morneau, VP,  Brian Lian, President & CEO,  and Matthew Foehr, Director
  • Insider trading is most common in January, with the busiest year in 2021

Viking Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1